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Although considerable information has emerged on the molecular properties of the p36 target protein its 
function as well as the possible implications of its tyrosine phosphorylation have remained elusive. Here 
we show that ail sequence segments of p36 published so far can be aligned by homology along the complete 
sequence of lipocortin, which has been reported recently. This alignment extends beyond multiple Geisow 
motifs, thought to indicate a sequence principle implicated in Caz+ and/or lipid binding. While the latter 
properties are already established for p36 one may expect them also for lipocortin, an inhibitor of phospho- 
lipase A, activity. Certain impli~tions of these results are discussed. 
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1. INTRODUCTION 
Geisow, Walker, Suedhof and their colleagues 
have studied over the last few years a set of 
Ca2+-dependent membrane-binding proteins 
possibly involved in exocytosis. For reasons only 
recently understood (see below) all these proteins 
reacted with a particular polyclonal antibody 
originally raised against a similar protein from the 
electric organ of Torpedo. Several experiments 
have led to the suggestion that these 
Ca2+-dependent membrane-binding proteins could 
contain repeating sequences ([l-6]; earlier review 
[71). 
We found independently that microvillus mem- 
brane vesicles derived from the intestinal 
epithelium contain two Ca2+-binding proteins in 
considerable amounts. These are lost from tradi- 
tional brush border prep~ations with well- 
preserved ultrastructure due to the use of EGTA. 
One of these proteins, ~36, was immediately 
recognized as the analogue of the fibroblastic p36 
known to be a major cytoplasmic target of 
retrovirally coded tyrosine-specific protein kinases 
[8]. Because of the general interest in this target 
protein and its modification we and others con- 
tinued to characterize p36 from intestinal 
epithelium where large-scale purification is easily 
possible [8, lo]. p36 shows moderate Ca’+ binding, 
which causes the ability of the protein to bind to F- 
actin as well as to spectrin [8,10]. Certain lipids 
such as phosphatidylserine strongly enhance the 
Ca2+ binding and both ligands render p36 a better 
substrate for phosphorylation by viral protein 
kinases ]I 11. p36 can form a heterotetramer in the 
presence of a unique pll protein [8,10]. pll is by 
amino acid sequence highly homologous to the 
SlOO protein ([12-141; for complete sequence see 
[12]), a Ca*+-binding protein of unknown function 
present primarily in glial cells. In spite of this rela- 
tion direct binding of Ca2+ has not yet been found 
for pll which, however, like SlOO is a dimer 
[lo, 121. In human epidermoid A431 cells, a ~35 
related [lo] to p36 seems the prime target of the 
tyrosine kinase [ 151 associated with the EGF recep- 
tor and there is suggestive vidence that free ~35 
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rather than the complex with pll is the preferred 
target [lo]. 
Having recently established two longer amino 
acid sequence stretches which characterized p36 as 
a unique protein and account for 23% of its length 
[16], we found no related protein in the sequence 
bank of the Biochemical Research Foundation. 
This conclusion is now changed by two papers 
published simultaneously with ours [l, 171. The 
complete c-DNA sequence of human lipocortin 
became available [ 171 and Geisow et al. determined 
the cross-reactivity of a particular antibody with 
several Ca’+-dependent membrane-binding pro- 
teins [ 11. They characterized short sequences which 
directly lead them to a consensus-type sequence. 
This seems to occur in several of these proteins 
more than once. As it is currently not known 
whether this motif reflects a novel Ca*+-binding 
site or a lipid-binding site or both, we shall refer to 
this sequence principle as the Geisow motif. In a 
short review, published at the same time, Kret- 
singer and Creutz [18] drew attention to the 
presence of the motif in lipocortin. This protein, 
formerly called lipomodulin [ 191, is an inhibitor of 
phospholipase AZ and thought to control the 
biosynthesis of the potent mediators of inflamma- 
tion, the prostaglandins and leukotrienes (reviews 
wv11). 
Here we show that the Geisow motif is present 
in p36 at least three times and also that p36 and 
lipocortin show extensive sequence homologies. 
Because of the ability to compare the longer se- 
quences of p36 with lipocortin we are in a better 
situation to describe the Geisow motif than the 
earlier report covering only short segments [l]. 
2. RESULTS AND DISCUSSION 
Although not noted by Wallner et al. [17] their 
human lipocortin sequence shows four consecutive 
segments with sequence homologies culminating in 
the motif region (fig.1). Three of these motifs 
which we call Lipo I, II and IV have been also 
noted by Kretsinger and Creutz [18]. They span 
residues 51-72, 123-144 and 282-303, respective- 
ly. The fourth site, Lipo III, situated around 
residues 207-228 may be functionally defective as 
a position always occupied by a large hydrophobic 
residue shows a hydrophilic asparagine. 
Our two sequence segments [16] or porcine p36 
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align very well with human lipocortin (fig.1). 
Thus, the amino-terminally located segment, 
which we call p36 I, shows the Geisow motif and 
is in this region particularly closely related to Lipo 
I. Within the region 13 out of 24 residues are iden- 
tical and there are several additional conservative 
replacements. This homology is higher than that 
seen when Lipo I and II are compared (11 identical 
residues). Our second sequence segment starting 
with the sole tryptophan of p36 can be aligned 
directly with the carboxy-terminal part of the 
motif. Although this alignment still requires con- 
solidating sequences on the amino-terminal end, 
we note that our previous experiments implicate 
this tryptophan in the Ca*+-induced difference 
spectra and fluorescence spectra [10,16]. Fig. 1 
shows that this segment, p36 III, which starts 
around residue 200 (see [16]) seems more closely 
related to Lipo III than to the other three motifs in 
lipocortin. Interestingly the short motif sequence 
of p36 reported by Geisow et al. [l] fits more close- 
ly to Lipo II and we have therefore tentatively 
labelled it p36 II. As the liver protein endonexin 
seems to have five repeating motifs [l] and lipocor- 
tin has four (see above) one might also expect a 
fourth motif for ~36. Given the alignment with 
lipocortin shown in fig. 1, such a putative site could 
be present relatively close to the carboxyl end of 
~36. 
With more and longer sequences now available 
(fig. 1) the motif sequences eem longer but display 
less absolute sequence requirements than thought 
earlier [l]. Invariant residues are a glycine and an 
arginine in positions 1 and 14 and two pairs of 
large hydrophobic residues present in positions 7, 
8, 10 and 11. Positions 8 and 10 show a striking 
preference for isoleucine. Most likely position 4 in- 
volves in the majority a glutamic acid. Interesting- 
ly all four motifs of lipocortin and p36 III display 
a tyrosine 12 residue past the invariant arginine 
(fig.1). Future experiments have to determine 
whether it is this type of tyrosine which in p36 is 
influenced in its spectral properties by Ca*+ 
binding [ 10,161. A similar tyrosine effect has been 
reported for a second protein of this group [22]. 
The particularly striking homology between p36 
I and Lipo I seems to extend in a moderate way 
towards the amino-terminal side (fig.1) and this 
also seems true for the other sites in lipocortin. 
Kretsinger and Creutz [ 181 raised the question as to 
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Endo 1 
Endo 2 
Endo 3 
Endo 4 
Endo 5 
Pmt. II 
p36 II 
~36 III 
~36 I 
Lip0 I 
LIP0 II 
LlPO III 
Lip0 IV 
NKGLGTDDDTLIRVMVSRAEIDD 
WGTDEVK 
GLGTDEDAIINVLAYR 
GAGTDEGSLIEILASR 
MKGAGTDEGCLIEILADRGPEEIR 
MKGLGTDEGAIIDVLAV 
MLGLGTDEDRLIEIIL - -__-_-- ---- 
200 
WISIMTERSVPHLQKVFSRVKS 
__-_ -- -- - 
9 * 
KLSLEGDHSTPASAVGSVKAVlNFDAERDALNIETAIKlKGVXEVTIVNILTNRSN _--.- -- --- - __ - --- 
~EYVQT~KS~KGGPG~AV~P~PTFNP~~D~AALNKAIMVKGVD~ATIIDILTKRNNAQRQQIKAAYL~~ 
__ _-- - -- --- - - 
91 158 
PLDETLKKALTGHLEEVVLALLKTPAQFDADELRAAHKGLGTDEDTLIEILASRTNKEIRDINRVYRE 
175 242 
DFRNALLSLAKGDRSEDFGVNEDLADSDARALVEAGERRKGTDVNVFNTILTTRSYPQLRRVFQKYTK 
250 317 
KVLDLELKGDIEKCLTAIVKCATSKPAFFAEKLHQANKGVGTRHKALIRIMVSRSEIDMNDIKAFYQK 
+ 0 00 00 t + 
Fig. 1. Sequence comparison between established longer fragments of porcine p36 and the sequence of human lipocortin. 
The four lipocortin sequences with corresponding residue numbers are taken from the complete sequence [17] and are 
labelled Lipo I-IV. The first five lines give the motif sequences found for bovine liver endonexin [l]. These are extended 
in lines 6 and 7 by short motif sequences reported for porcine intestinal epithelium protein II and porcine p36 from 
lymph nodes, respectively [l]. The two longer sequence segments labelled p36 I and III are from our study on p36 from 
intestinal porcine epithelium [16,25]. The approximate position of the Geisow motif is indicated by a line at the bottom. 
Note the invariant glycine and arginine in positions 1 and 14 indicated by + and two pairs of large hydrophobic residues 
at positions 7, 8, 10 and 11 indicated by a circle (see text). Also note that the longer sequences how a tyrosine 12 residues 
past the invariant arginine (circle). Residues underlined indicate identities between corresponding pairs of sequences: 
Lipo I I p36 I, Lipo II lp36 II and Lipo III I p36 III. Additional conservative replacements are not indicated to avoid 
overburdening the figure. Note, however, the corresponding homologies in the other sequences. Residue numbers for 
p36 are known only approximately [13,16,26]. For bovine p36 also the first 29 residues of p36 I are known [ 131. They 
differ only by a proline (position 20) from the sequence given for the porcine protein [26]. The tyrosine phosphate is 
indicated by a star (131. 
whether the position of phosphorylatable tyrosine 
residues could be related for both proteins. In p36 
the tyrosine phosphate occurs [13] at position 23. 
Although phosphorylation of lipocortin [l&19] is 
thought to be functionally important, the position 
of the residue is not known. If it were located at 
either position 21 or 39 it would occur at a relative- 
ly similar distance from the first motif sequence in 
both proteins, although the surrounding sequences 
differ from each oth,er and from those found in the 
auto-phosphorylation site of the protein kinases 
[91. 
Whether the repeating motifs are indeed in- 
volved in Ca2+ and/or lipid binding will require 
studies on suitably small fragments or mutational 
studies on recombinant lipocortin. Although not 
established for lipocortin, certain other members 
of this family of proteins are already known to 
bind Ca2+ and for some of them multiple Ca2+ 
sites have been inferred from terbium fluorescence 
or Ca’+-dependent spectroscopical studies 
[3,4,6,10,22-241. Lipid binding is established at 
least for a few of these proteins [l , 11,161 and it 
seems to involve always lipids present in the 
cytoplasmic leaflets of the plasma and en- 
doplasmic reticulum membranes. Some proteins of 
the group have in addition protein ligands. 
Lipocortin is a phospholipase A2 inhibitor [19-211 
97 
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and p36 binds to pll and the cytoskeletal com- 
ponents F-actin and spectrin [8,10,12]. In p36 the 
major binding site for pl 1 resides in the loose do- 
main preceding the first motif [16]. The presence 
of lipocortin in peritoneal exudates and culture 
medium of neutrophils seems to support the earlier 
notion that such proteins could be involved in 
exocytosis [2,6]. The presence of two related pro- 
teins in the microvilli of the intestinal epithelial cell 
[8] raises the question of whether they could also 
provide a submembraneous lining in a cellular ex- 
tension otherwise stabilized by the core filament 
bundle of F-actin and its associated proteins 
(reviews [25,26]). 
REFERENCES 
[II 
PI 
[31 
I41 
151 
WI 
[71 
PI 
191 
[lOI 
Geisow, M.J., Fritsche, U., Hexham, J.M., Dash, 
B. and Johnson, T. (1986) Nature 320, 636-638. 
Walker, J.H. (1982) J. Neurochem. 39, 815-823. 
Walker, J.H., Obrocki, J. and Suedhof, T.C. 
(1983) J. Neurochem. 41, 139-145. 
Suedhof, T.C., Ebbecke, M., Walker, J.H., 
Fritsche, U. and Boustead, C. (1984) Biochemistry 
23, 1103-1109. 
Suedhof, T.C. (1984) Biochem. Biophys. Res. 
Commun. 123, 100-107. 
Geisow, M.J., Childs, J., Dash, B., Harris, A., 
Panayotou, G., Suedhof, T.C. and Walker, J.H. 
(1984) EMBO J. 3, 2669-2674. 
Owens, R.J. and Crumpton, M.J. (1984) Biochem. 
Essays 1, 61-63. 
Gerke, V. and Weber, K. (1984) EMBO J. 3, 
227-233. 
Hunter, T. and Cooper, J.A. (1985) Annu. Rev. 
Biochem. 54, 897-903. 
Gerke, V. and Weber, K. (1985) J. Biol. Chem. 
260, 1688-1695. 
[Ill 
WI 
1131 
[I41 
[I51 
[I61 
t171 
[I81 
1191 
WI 
1211 
WI 
~231 
v41 
v51 
WI 
1271 
Glenney, J.R. jr (1985) FEBS Lett. 192, 79-82. 
Gerke, V. and Weber, K. (1985) EMBO J. 4, 
2917-2920. 
Glenney, J.R. jr and Tack, B.F. (1985) Proc. Natl. 
Acad. Sci. USA 82, 7884-7888. 
Hexham, J.M., Totty, N.F., Waterfield, M.D. and 
Crumpton, M.J. (1986) Biochem. Biophys. Res. 
Commun. 134, 248-254. 
Fava, R.A. and Cohen, S. (1984) J. Biol. Chem. 
259, 2636-2645. 
Johnsson, N., Vandekerckhove, J., Van Damme, 
J. and Weber, K. (1986) FEBS Lett. 198, 361-364. 
Wallner, B.P., Mattaliano, R.J., Hession, C., 
Cate, R.L., Tizard, R., Sinclair, L.K., Foeller, C., 
Chow, E.P., Browning, J.L., Ramachandran, K.L. 
and Pepinsky, R.B. (1986) Nature 320, 77-80. 
Kretsinger, R.H. and Creutz, C.E. (1986) Nature 
320, 573. 
Hirata, F., Matsuda, K., Notsu, Y., Hattori, T. 
and Del Carmine, R. (1984) Proc. Natl. Acad. Sci. 
USA 81, 4717-4721. 
Flower, R.J., Wood, J.N. and Parente (1984) Adv. 
lnflammation Res. 7, 61-69. 
Hirata, F. (1984) Adv. Inflammation Res. 7, 
71-78. 
Shadle, P.J., Gerke, V. and Weber, K. (1985) J. 
Biol. Chem. 260, 16354-16360. 
Owens, R.J. and Crumpton, M.J. (1984) Biochem. 
J. 219, 309-316. 
Owens, R.J., Gallagher, C.J. and Crumpton, M.J. 
(1984) EMBO J. 3, 945-952. 
Weber, K. and Glenney, J.R. jr (1982) Phil. Trans. 
R. Sot. Lond. B 299, 207-214. 
Mooseker, M.S. (1985) Annu. Rev. Cell Biol. 1, 
209-241. 
Johnsson, N. (1986) Diploma Thesis, University of 
Tdbingen, FRG. 
98 
